Compare ImmunityBio Inc. Common Stock (IBRX) vs Lumentum (LITE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Lumentum — how do they compare? ImmunityBio Inc. Common Stock trades at $10.02 (market cap $10.33B), while Lumentum trades at $1,079.64 (market cap $100.64B). The key difference: Lumentum is far larger — about 9.7× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is more actively traded (11,745,198 versus 3,383,346). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Lumentum for 4 Days on average.
| IBRX | LITE | |
|---|---|---|
Market Cap | $10.33B | $100.64B |
Volume | 11,745,198 | 3,383,346 |
Sector | Health | Technology |
52-Week High | $11.55 | $1.13K |
52-Week Low | $1.98 | $149.61 |
Typical Hold Time | 0 Days | 4 Days |
Enterprise Value | $10.79B | $99.58B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Lumentum
Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.
Read more on LITE →
